Related by context. All words. (Click for frequent words.) 65 FOLOTYN ® 63 samarium Sm 63 ThermoDox ® clinical 63 lexidronam injection 62 kidney urologic 62 GSK '# 62 ALN HPN 61 Ridaforolimus 61 QUADRAMET R 61 romazarit 61 candidate CRLX# 61 tramiprosate Alzhemed TM 61 HuCAL antibody 60 Albugon 60 ATL/TV# 60 Curaxin CBLC# 60 lucinactant 60 TRANSDUR ™ 60 HCV NS5B polymerase 60 CYT# potent vascular disrupting 60 phase IIb clinical 60 commercialize apixaban 60 PROSTASCINT R 60 budesonide foam 60 Phase 1b clinical trials 59 YONDELIS 59 Aplidin R 59 Phase #b/#a clinical 59 Adenosine Therapeutics 59 CD# monoclonal antibody 59 Locked Nucleic Acid 59 familial amyloidotic polyneuropathy FAP 59 Cerebral Amyloid Angiopathy 59 systemic Phase 1b 59 Cerebril TM 59 myelofibrosis polycythemia vera 59 http:/www.pharmacopeia.com 59 RELOVAIR ™ 58 leukotriene pathway 58 EXPLORE Xa 58 investigational oral anticoagulant 58 Azedra 58 Safinamide 58 preclinical efficacy 58 Kosan dependence 58 solithromycin 58 Prednisporin 58 Syncria 57 gastro intestinal inflammation 57 GERD migraine headaches 57 LHRH antagonists 57 sorafenib tablets 57 Idera Pharmaceuticals 57 Phase Ib II 57 www.ilgenetics.com 57 Phase Ib clinical 57 Phase IIb III 57 lomitapide 57 MT#/MEDI-# 57 Mipomersen 57 Epidermal Growth Factor Receptor 57 GeneICE 57 Systemic Delivery 57 Phase III Clinical Trial 57 MEND CABG 57 Medidur TM FA 57 CCX# 57 AEG# 57 HepeX B 57 malignant mesothelioma Alfacell 57 Combination REOLYSIN R 57 AZD# TC 57 cardio renal 56 TransVax ™ 56 MelaFind R 56 MEK Inhibitor 56 R#/MEM # 56 R lenalidomide 56 GRNCM1 56 GATTEX TM 56 GPR# agonist 56 By JENNIFER LEARN 56 EnVivo 56 Phase 2a Trial 56 Randomized Double blind 56 IL# PE#QQR 56 Novel Oral 56 Fabry Disease 56 ALN TTR 56 SNT MC# 56 First Patient Enrolled 56 ETEC vaccine 56 ASPIRE HIGHER 56 NASDAQ ABII 56 See CLINICAL PHARMACOLOGY 56 CEQ# 56 Phase Ib study 56 CIMZIA ™ 56 Entereg TM 56 rALLy clinical trial 56 targeting miR 56 Phase III Clinical Trials 56 Virulizin R 56 number NCT# ClinicalTrials.gov 56 BioNumerik 56 Preclinical Efficacy 56 intravesical infusion therapy 56 Fibrillex TM 56 Opexa Therapeutics 56 Alligator Bioscience AB 55 Teplizumab 55 Zenvia ™ 55 hyperphenylalaninemia HPA due 55 PSMA ADC 55 miRNA therapeutics 55 Etubics 55 non alcoholic steatohepatitis 55 Zor Pharmaceuticals 55 recurrent glioma 55 immunoregulation 55 specific CCR9 antagonist 55 phase IIa clinical 55 Crit Rev 55 Phase 2b Clinical Trial 55 HQK 55 Intarcia 55 Phase IIa trials 55 elotuzumab 55 Therapeutic Antibodies segment 55 Biomarker Study 55 STRIDE PD 55 TRO# 55 Prostate AdenoCarcinoma Treatment 55 EGFR HER2 55 Emisphere Technologies 55 Innovive Pharmaceuticals 55 Hsp# Inhibitor 55 ADVANCE PD 55 Catheter Associated 55 MET amplification 55 CHAMPION PCI 55 XL# SAR# 55 Vernalis plc 55 Alocrest 55 Quark Biotech 55 Triolex 55 Apaziquone 55 Acute Decompensated Heart Failure 55 cat dander allergy 55 transthyretin TTR mediated amyloidosis 55 MYCAMINE 55 Truvada tablets 55 AKIP TM 55 Faropenem 55 Vascugel ® 55 JUVISTA 54 please visit www.lexpharma.com 54 Phase Ib Clinical Trial 54 Phase #b/#a 54 Immunotherapeutic 54 ExTRACT TIMI 54 HGS# 54 ACTCellerate 54 MGd 54 Arno Therapeutics 54 Cerimon 54 Phase Ib IIa 54 Clinical Trial Data 54 BRIM3 54 J Antimicrob Chemother 54 Virulizin ® 54 Dacogen injection 54 Alnylam #x# 54 direct thrombin inhibitors 54 Topline Results 54 Tarvacin TM 54 glucokinase activator 54 phase IIb trial 54 AVN# Phase 54 Hemorrhagic Stroke caused 54 multicenter Phase II 54 Study Evaluating 54 CB2 selective 54 CINtec R 54 pharmacodynamic profiles 54 Syllego system 54 Prestara 54 Epratuzumab 54 riociguat 54 Inflammatory Diseases 54 Decitabine 54 PRTX 54 ALN VSP Phase 54 Daclizumab 54 Trandolapril 54 invasive candidiasis 54 mg BID dose 54 Oasmia 54 Phase 2b Trial 54 Tumor Response 54 Phase #/#a 54 Piramed 54 Diabetic Macular Edema 53 Alzheimer disease cognitive impairment 53 AA amyloidosis 53 azathioprine monotherapy 53 Vegenics 53 Aflibercept 53 pancytopenia 53 Montigen 53 Ranolazine 53 complement inhibitor eculizumab 53 Pivotal Trial 53 Pivotal Phase 53 basal bolus regimen 53 multicenter randomized Phase III 53 Enzastaurin 53 Novolimus 53 Preclinical Study 53 FermaVir 53 initiate multicenter 53 Clinical Trial Results 53 InterfeRx TM 53 keloid scarring 53 Galderma SA 53 Ore Pharmaceuticals 53 antisense inhibitors 53 depsipeptide 53 paroxysmal nocturnal hemoglobinuria 53 intravenous methylnaltrexone 53 Cardiotoxicity 53 MCU cardiovascular 53 Refractory Angina 53 DeveloGen 53 Advanced Renal Cell 53 Diabetic Nephropathy 53 FoldRx Pharmaceuticals Inc. 53 Intravenous CP 53 CIMZIA TM certolizumab pegol 53 Cellgate 53 Outpatient Setting 53 Genta Incorporated OTCBB GETA 53 GDIR 53 EchoCRT 53 BR.# 53 Lomitapide 53 GRN# 53 Tranzyme Pharma 53 Degarelix 53 Hematological 53 Immunomedics Inc 53 acute humoral rejection 53 lumiliximab 53 ERYtech 53 Brentuximab Vedotin SGN 53 brivaracetam 53 Halozyme Ultrafast Insulin 53 Cascade LifeSciences 53 Hereditary angioedema HAE 53 NASDAQ ISIS 53 Invasive pneumococcal disease 53 AKIP 53 vitro pharmacology 53 Stapled Peptide 53 Inotek 53 Prospective Randomized 53 GI motility disorders 53 Clinical Trials Update 53 Quark Pharmaceuticals 53 HDAC Inhibitor 52 SW3d #,#-# Tex. Crim 52 IMPACT DCM 52 Oral Fingolimod 52 neurogenic orthostatic hypotension 52 oral ridaforolimus 52 Gemin X 52 Rilonacept 52 Celmed 52 Recurrent Breast Cancer 52 placebo controlled Phase 52 oral deforolimus 52 Enanta 52 Golimumab 52 II Clinical Trial 52 Coley Pharmaceutical Group 52 neratinib 52 aptamer therapeutics 52 oral FTY# 52 Unither 52 Eculizumab 52 microplasmin Phase III 52 Ganite ® 52 tolerability pharmacokinetics 52 www.palatin.com 52 Hybridon 52 EMPOWER ™ 52 European Sepsis Trial 52 Metaphore 52 Antisense Drug 52 posaconazole 52 sells Osteocel R 52 metastatic neuroendocrine tumors 52 Tanespimycin 52 Peptidomics 52 Quark Biotech Inc. 52 Phase IIIb 52 POTELLIGENT R Technology 52 Immunogenicity 52 Cytomegalovirus CMV 52 ISTODAX 52 relapsed MM 52 Serious Adverse Events 52 DelSite Biotechnologies Inc. 52 Medidur FA 52 phase IIb 52 CRLX# 52 Nephrol Dial Transplant 52 vascular endothelial dysfunction 52 Sensipar R 52 Arch Neurol 52 FASEB J. 52 Randomized Clinical Trials 52 ATTR 52 plasma kallikrein 52 Prolongs Survival 52 iCo 52 DAS# Fludase ® 52 Carotid Revascularization Endarterectomy vs. 52 Dose escalation 52 LUX Lung 52 NELTY 52 Cytokine PharmaSciences 51 Phase IIIb clinical 51 SuperAntibody 51 ONTARGET 51 Multicenter Randomized 51 PAOD 51 dacetuzumab 51 Deforolimus 51 Kidney Int 51 Antisense Therapeutics 51 Tesmilifene 51 Eluting Stent 51 ESBATech 51 peritumoral brain edema 51 LibiGel Phase III 51 Lung Rx 51 Acute Ischemic Stroke 51 simplex virus 51 Nasdaq RXII 51 phase Ib 51 Traumatic Spinal Cord Injury 51 Xoma Ltd 51 Zenvia Phase III 51 retinal vein occlusion 51 antibody humanization 51 Double Blind Placebo 51 blinded randomized placebo controlled 51 Urumalqui 51 hepatitis C HCV 51 ARCOXIA 51 Amikacin Inhale 51 Isis Pharma 51 Fungal Infections 51 Hepatitis C Infection 51 ORAL Solo 51 phase IIb study 51 Ascent Therapeutics 51 Isis Pharmaceuticals NASDAQ 51 Randomized Clinical Trial 51 Aegera 51 placebo controlled Phase III 51 Galenea 51 Oral Mucositis 51 NO# [002] 51 Amira Pharmaceuticals 51 hGH CTP Phase 51 telaprevir dosed 51 Naglazyme R 51 Syntonix 51 FoldRx 51 Ophthotech 51 TRA 2P 51 pexelizumab trials 51 Cobalamin 51 Obes Res 51 J Clin Endocrinol Metab 51 Tranzyme 51 Isotechnika Pharma 51 Taligen Therapeutics 51 Severe Sepsis 51 Pivotal Clinical Trial 51 Isis Alnylam 51 bepotastine besilate nasal spray 51 Sunesis Pharma 51 NeuroMedix 51 double blinded placebo 51 Agios Pharmaceuticals 51 Metastatic Melanoma 51 CIMZIA TM 51 Epitomics 51 Hypertensive adverse reactions 51 MERLIN TIMI 51 clinical pharmacology studies 51 Valera Pharmaceuticals 51 Preclinical Development 51 Antitumor Activity 51 Pivotal Study 51 PsychoGenics 51 CALGB # [002] 51 Anthracycline 51 FivePrime Therapeutics 51 Progenitor Cells 51 acute onset CINV 51 severe oral mucositis 50 Malignant Melanoma 50 Aortic Stenosis 50 AltaRex 50 AeroLEF TM 50 Idun Pharmaceuticals 50 Hepatotoxicity 50 Nventa 50 Panitumumab 50 International Verapamil SR 50 Micropump 50 Computed Tomographic 50 RECORD1 50 Phase III ThermoDox 50 DAPT Study 50 Preclinical Models 50 Pulmonary arterial hypertension PAH 50 KAI Pharmaceuticals 50 randomized controlled Phase 50 dirucotide 50 PRE SURGE 50 Arch Dis Child 50 sunitinib malate 50 Pervasis Therapeutics Inc. 50 corneal transplant rejection 50 Phase 1b trial 50 BioRexis 50 GVAX Pancreas Vaccine 50 Randomized Double Blind 50 diabetes hyperlipidemia 50 Diamyd Medical Diamyd 50 Ondine Biopharma Corporation 50 Fovea Pharmaceuticals 50 psoriatic arthritis PsA 50 ENZON 50 Cardiac Allograft Rejection 50 APEX PD 50 longitudinal observational study 50 AA Amyloidosis 50 HCV Protease Inhibitor 50 Isis Pharmaceuticals Inc 50 Syntonix Pharmaceuticals 50 relapsing multiple sclerosis 50 Randomized Phase II 50 Blinatumomab 50 CR# vcMMAE 50 Patient Accrual 50 AVEO integrates proprietary 50 Euroscreen 50 Lymphocytic 50 GOUT 50 NGFN 50 LEAD Therapeutics 50 Valsartan 50 Hypertriglyceridemia 50 chronic HCV infection 50 Cortoss TM 50 ISIS # 50 Hepatocellular Carcinoma HCC 50 Apixaban 50 p# biomarker 50 HuLuc# 50 Drug Prevents 50 Lexicon Pharmaceuticals 50 AIR CF2 50 ERATO 50 Biological Therapy 50 Samjin 50 trastuzumab Herceptin ® 50 Leber Congenital Amaurosis LCA 50 Advaxis Phase 50 TargeGen 50 INDEPENDENT SPORTS EDITOR 50 Exelixis XL# 50 Ardea Biosciences 50 Prelude SkinPrep System 50 Neuroendocrine Tumors 50 Phase III multicenter 50 HCV SPRINT 50 NABTT 50 HoFH 50 prospective randomized multicenter 50 Addrenex 50 Velaglucerase alfa 50 Nereus Pharmaceuticals Inc. 50 tesmilifene 50 systemic RNAi 50 HeFH 50 PhiloGene 50 J Immunol 50 iCo Therapeutics 50 Combination Treatment 50 mRNA antagonists 50 Nonclinical 50 TRANSFORMS 49 CombinatoRx Incorporated 49 J Clin Invest 49 EURONEXT SAN 49 essential thrombocythemia 49 Archemix Corp. 49 EQUIP OB 49 Acute myeloid leukemia AML 49 Oramed 49 TG MV 49 SR Pharma 49 BLOOM Behavioral modification 49 Peggy Pinkston 49 Stenting Trial CREST 49 Treating Chronic 49 Vicor Technologies 49 Agenerase 49 HER2 overexpression 49 Pooled Analysis 49 Micrologix Biotech Inc. 49 Metabasis Therapeutics Inc. 49 Nasdaq ISIS 49 Amrubicin 49 MacuCLEAR 49 pharmacokinetic PK 49 ANCHOR trial 49 Phase Ib 49 TACI Ig 49 CAMMS# 49 ISIS Pharmaceuticals 49 TMC# C# 49 Lupuzor 49 Hepatocellular Carcinoma 49 Psoriatic arthritis 49 Demonstrates Sustained 49 Phase IIIb study 49 Non Alcoholic Fatty 49 dose escalation clinical 49 Helix BioMedix Inc. 49 Chronogen 49 transcranial Doppler ultrasound 49 Syrrx 49 Arch Intern Med 49 Chronic Heart Failure 49 BioInvent 49 Chronic Liver Disease 49 MIVI TRUST 49 Excaliard 49 Renal Cancer 49 Herceptin Rituxan 49 Nuevolution 49 Efficacy Trial 49 Aegera Therapeutics 49 Diabet Med 49 NATRECOR R 49 proprietary NexACT ® 49 Rasilez Tekturna 49 Delcath Phase III 49 DOV Pharmaceutical Inc. 49 angiogenesis inhibition 49 Neurome 49 Decompensated Heart Failure 49 Prism Pharmaceuticals 49 Sezary syndrome 49 Cephalon GlaxoSmithKline Organon 49 lorcaserin Phase 49 recurrent glioblastoma multiforme 49 Antiviral Therapy 49 chronic myocardial ischemia 49 LHON 49 ExCell study 49 Salmedix 49 ATIR TM 49 FAME Study 49 AngioGenex 49 CAPACITY trials 49 SUCCEED trial 49 Ortho Biotech Oncology 49 PEGylated interferon beta 1a 49 Uterine Cancer 49 J Neurosci 49 ENDEAVOR IV 49 Controlled Trial 49 Estybon ™ 49 Predict Risk 49 Ibis Biosciences 49 AutoImmune 49 dirucotide MBP# 49 Breast Cancer Recurrence 49 Alnylam Biotherapeutics 49 CureDM 48 Pfizer Regenerative Medicine 48 Non Alcoholic Steatohepatitis 48 Projected Release Date 48 VentiRx 48 Regulus Therapeutics 48 Ceragenix 48 Respiratory Distress 48 Metabolex 48 Myrexis 48 antisense drugs 48 Merrimack Pharmaceuticals 48 Decision Biomarkers 48 WHO TDR 48 Sunesis Pharmaceuticals 48 COSIRA trial 48 DiaKine 48 Virdante 48 commercialize microRNA 48 Clostridium difficile Infection 48 refractory CLL 48 Enzo Therapeutics 48 Idera Pharma 48 venous thromboembolic events 48 Phenomix 48 CONQUER OB 48 Controlled Study 48 Sorafenib HCC Assessment 48 Biosyn 48 Clinical Outcome 48 CERVARIX 48 Prospective Multicenter 48 Aranka Gold 48 Ibis T# TM 48 danoprevir 48 Autologous Stem Cell Transplantation 48 Ovarian Cancers 48 MacroChem 48 dysglycemia 48 Hosp Epidemiol 48 Diabetic Retinopathy 48 Inpharmatica 48 PharmaFrontiers 48 Zacharon 48 NYHA Class II 48 ALSYMPCA 48 J Virol 48 ICAEL 48 placebo controlled clinical 48 NovaBay 48 Squamous 48 allogeneic bone marrow 48 Velcera 48 PRoFESS 48 Antisense 48 ABSORB clinical 48 R# #mg BID 48 Malignant Glioma 48 Angioblast 48 OncoMed Pharmaceuticals 48 Double Blind Randomized 48 REVIVE Diabetes 48 Verus Pharmaceuticals Inc. 48 APD# 48 stem cell engraftment 48 Renal Cell Carcinoma RCC 48 ParAllele 48 Arrow Therapeutics 48 Gentium Announces 48 Enanta Pharmaceuticals 48 www.gene.com 48 standard chemotherapy regimen 48 Bayhill Therapeutics 48 J Rheumatol 48 multicenter Phase 48 cancer mCRC 48 Regulus Alnylam 48 Prima BioMed 48 Adult Stem Cell Therapy 48 RE LY ® 48 gastrointestinal adverse reactions 48 Critical Limb Ischemia CLI 48 Alantos 48 Progenics Pharmaceuticals 48 Roche OTC RHHBY 48 transplantation HCT 48 GlycArt 48 SUTENT 48 Regulus Therapeutics LLC 48 Haptoglobin 48 Serious Infections 48 PROSTVAC TM 48 multicenter placebo controlled 48 TIMI Study Group 48 oral mucositis OM 48 Portal Hypertension 47 Ischemic 47 Intervention Trial GAIT 47 Transition Therapeutics 47 Gastrotech 47 Randomized Controlled Trials 47 CancerGuide 47 Coronary Artery Bypass Graft 47 immunodeficiencies 47 bladder augmentation 47 LUMINATE 47 Catheter Ablation 47 clevudine 47 PNH Registry 47 outlicensing 47 Charles Dullin School 47 Paroxysmal Nocturnal Hemoglobinuria PNH 47 pediatric acute lymphoblastic 47 Rigel Pharmaceuticals 47 RE MODEL 47 Astex Therapeutics 47 OLYMPIA registry 47 atypical Hemolytic Uremic Syndrome 47 Bronchiectasis 47 cytomegalovirus infection 47 REUTERS Edgard Garrido 47 AcuFocus 47 Iroko Pharmaceuticals LLC 47 ChemoCentryx 47 ENESTnd 47 Inflammatory Markers 47 Catalyst Biosciences 47 Metabasis 47 Synta Announces 47 Chronic Hepatitis C 47 B. Lynne Parshall 47 acute PAO 47 ARYx Therapeutics 47 Polymeropoulos 47 Max Neeman 47 Xenon Pharmaceuticals 47 ACZ# 47 #F FDG PET 47 Ibritumomab Tiuxetan 47 Pulmonary arterial hypertension 47 LFRP 47 APTIVUS r 47 Zosano 47 RE LY 47 Hemorrhagic Stroke 47 liver transplantations 47 Charlesson 47 Altus Pharmaceuticals 47 Peripheral Blood 47 recurrent NSCLC 47 metastatic castration resistant 47 Biolipox 47 commercialize elagolix 47 Portola Pharmaceuticals 47 Therapeutic Arthritis 47 Contrast Echocardiography 47 prospective multicenter study 47 viral kinetics 47 PETITION FOR REVIEW DENIED 47 Clostridium Difficile Associated 47 TransTech Pharma 47 SE5 OH containing 47 Randomized Study 47 XIENCE V PROMUS Stent 47 Western Airborne Contaminants 47 exploratory endpoints 47 Solid Tumors 47 registrational 47 AcelRx Pharmaceuticals 47 Caprion 47 Radioimmunotherapy 47 retinal dystrophies 47 http:/www.isispharm.com 47 membranous nephritis 47 randomized multicenter Phase III 47 transplantation HSCT 47 BioZone 47 REVEAL Registry 47 Interagency Registry 47 Therapy Evaluation 47 Idiopathic pulmonary fibrosis 47 NCT# ClinicalTrials.gov 47 EMPHASIS HF trial 47 Infinity Pharmaceuticals 47 renal biopsy 47 Phase III metastatic melanoma 47 HPTN 47 cutaneous T cell 47 Corautus Genetics 47 BioSeek 47 Altair Therapeutics 47 APEX AMI trial 47 PROSTVAC VF 47 grade cervical intraepithelial 47 Rexahn 47 Calixa 47 Knopp Neurosciences 47 CHDI Foundation 47 AIR CF1 47 Nastech Pharmaceutical Company 47 Pulmonary Arterial Hypertension 47 Hodgkin lymphoma HL 47 Juvenile Idiopathic Arthritis 47 Aggressive Reduction 46 Furiex Pharmaceuticals 46 Leukemias 46 HemoShear 46 Symphogen 46 TITLE Auctions 46 Adjuvant Chemotherapy 46 Endometrial Cancer 46 INSEEC Schools 46 Multicenter Phase 46 DAPT 46 Proneuron 46 Idenix Pharmaceuticals 46 Zalicus 46 Inc MEDX 46 Takeda Kyowa Hakko 46 Halozyme 46 cobas HPV Test 46 Ceregene 46 Dimerix 46 Novel Approaches 46 Myriad Pharmaceuticals 46 specified secondary endpoints 46 postmenopausal osteoporotic women 46 TEN proforma fleet 46 Syndax 46 CorNova 46 Inflazyme 46 Glioma 46 ISEL 46 null responder HCV 46 Acute Renal Failure 46 Catabasis 46 Thiakis 46 PERSEUS clinical program 46 Iron Overload 46 invasive aspergillosis 46 Dr. Pingpank 46 Corcept 46 photodisinfection technology 46 Phase #/#a trial 46 Ischemia 46 Innodia 46 Santaris 46 NSABP B 46 NCCTG N# 46 AVINZA ® 46 BCIRG 46 aTyr Pharma 46 ENDEAVOR clinical 46 Chronic Myeloid Leukemia 46 APTIVUS 46 Alnylam Pharmaceuticals Nasdaq ALNY 46 Infarct 46 CorMedix 46 Chiral Quest 46 Athena Neurosciences 46 Affinitak 46 ForSight Newco II 46 MultiCell 46 ActivX Biosciences 46 Stenting Trial 46 Edge STudy 46 Cardiovascular Outcomes 46 BioSurgery 46 Myelodysplastic syndromes MDS 46 ARIXTRA 46 IGI Laboratories 46 Renal Cell Carcinoma 46 Am J Pathol 46 Paramount BioSciences 46 5 HT2C 46 SynthRx 46 enGene 46 GeneraMedix 46 Alnylam Pharma 46 Onrigin TM 46 ATryn ® GTC 46 ChondroGene 46 ARCALYST ® rilonacept 46 Montezuma Mines 46 multicenter randomized double 46 Genetic Variation 46 ONTARGET R 46 ORACLE MS 46 Sentinel Lymph Node 46 BiTE antibody MT# 46 Dr. Gorodeski 46 CABG Surgery 46 Napo Pharmaceuticals 46 Left Ventricular Hypertrophy 46 AEterna Zentaris 46 ALNY 46 MDV# 46 Newly Diagnosed Multiple Myeloma 46 commercialization milestones 46 Long Lesion 46 XenoPort 46 Ablaris Therapeutics 46 ProGenTech 46 Hyperthermia Therapy 46 AnGes MG Inc. 46 Neoadjuvant Chemotherapy 46 Phase III psoriasis 46 Theraputics 46 intermittent claudication 46 atherothrombotic disease 46 Randomized Evaluation 46 Intellikine 46 Helicon Therapeutics 46 Hana Biosciences 46 Sleep Disturbances 46 Vipin K. 46 Heart Failure Patients 46 Genelabs Technologies 46 Heart Failure Trial 46 Prenatal Alcohol 46 Venous Thromboembolism VTE 46 InSite Vision 46 Tacere 46 Kalbitor 46 Migenix 46 ankylosing spondylitis AS 46 multicenter phase 46 Memgen 46 Radiation Induced 46 Sipuleucel T 46 Cervista HPV 46 prospective observational 45 Renal dysfunction 45 registrational trial 45 Surgical Treatment 45 Locus Pharmaceuticals 45 Velcade bortezomib 45 EORTC 45 TCGA Pilot Project 45 follicular lymphoma FL 45 Tragara Pharmaceuticals Inc. 45 Alnylam ALNY 45 AVERROES 45 ImaRx 45 Muscle Function 45 Advanced Pancreatic Cancer 45 Refractory Peripheral T 45 Subgroup Analysis 45 Prospective Randomized Double 45 ImmuPharma 45 CoNCERT 45 Unresectable 45 metastatic RCC 45 Glenveigh 45 Randomized Phase III 45 Arterioscler Thromb Vasc Biol 45 Shortened telomeres 45 Mln Share Buyback 45 Kyowa Hakko Kirin 45 Xenogen Corporation 45 Mol Med 45 Hematological Cancers 45 Experimental Vaccine 45 Beactica 45 Tolerx 45 myelodysplastic syndrome MDS 45 Trypanosomiasis 45 Proximagen 45 Spectrum Pharmaceuticals 45 Screening Trial 45 Randomized Placebo Controlled 45 cenderitide 45 PolyTherics 45 Vertebral Fractures 45 5RTI 45 Phyterra Bio Inc. 45 atherogenic dyslipidemia 45 INTERHEART study 45 Array BioPharma 45 ALZA Corporation 45 Geochimica et Cosmochimica Acta 45 Genes Predict 45 Ipsen SA 45 Growth Hormone Deficiency 45 Genelabs 45 Alzheimer Immunotherapy Program 45 enzastaurin 45 www.isispharm.com 45 ROCKET AF 45 Gynecol Oncol 45 TAXUS V 45 pancreatic islet cell 45 Inc EXEL 45 Hyperlipidemia 45 Anacor 45 HBeAg negative 45 Neurologix 45 Autoimmunity 45 CTRC AACR San Antonio 45 Robert Motzer MD 45 Serenex